Literature DB >> 11686505

Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography.

M Hauser1, B S Gibson, N Wilson.   

Abstract

UNLABELLED: Anthracyclines are used in the therapy of several of the most common paediatric oncological disorders. The usefulness of these agents is limited by cardiotoxicity, with congestive heart failure developing in up to 20% of patients. To stratify possible risk factors, we investigated 38 children with acute lymphoblastic leukaemia for signs of late cardiomyopathy. Exercise-spiroergometry and stress-echocardiography with measurement of fractional shortening (FS) and ejection fraction (EF) as indicators of left ventricular function were performed. ECG, 24 h Holter monitoring, chest X-ray, virus serology and carnitine were analysed. Control subjects were 38 healthy children matched for age and body surface area. All 38 patients had normal echocardiographic findings at rest (EF: 0.73 +/- 0.06; FS: 0.35 +/- 0.05). ten patients had a significant attenuation of left ventricular function after exercise assessed by stress-echocardiography compared to the remaining 28 patients and 38 healthy control subjects (EF: 0.52 +/- 0.08 versus 0.77 +/- 0.06 and 0.80 +/- 0.08; FS: 0.29 +/- 0.06 versus 0.39 +/- 0.05 and 0.41 +/- 0.02); patients with reduced ventricular function after exercise had significant low anaerobic threshold, subnormal maximal oxygen uptake and decreased carnitine levels. The findings were not related to the dosage of administered doxorubicin. There exists no correlation between ECG, 24 h ECG, chest X-ray, virology and left ventricular dysfunction. The benefit of angiotensin converting enzyme inhibitors and the administration of carnitine remains speculative.
CONCLUSION: exercise-spiroergometry and stress-echocardiography are sensitive investigations for diagnosing subclinical cardiomyopathy late after completion of chemotherapy. Investigative findings of cardiomyopathy are not dose related and may provide information for therapeutic prevention before clinical symptoms of cardiomyopathy appear.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686505     DOI: 10.1007/s004310100830

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Near infrared spectroscopy (NIRS) as a new non-invasive tool to detect oxidative skeletal muscle impairment in children survived to acute lymphoblastic leukaemia.

Authors:  Francesca Lanfranconi; Luca Pollastri; Alessandra Ferri; Donatella Fraschini; Giuseppe Masera; Giuseppe Miserocchi
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

2.  Short and long-term impairments of cardiopulmonary fitness level in previous childhood cancer cases: a systematic review.

Authors:  Vesile Yildiz Kabak; Patrick Calders; Tulin Duger; Jibril Mohammed; Eric van Breda
Journal:  Support Care Cancer       Date:  2018-09-25       Impact factor: 3.603

3.  Exercise capacity in apparently healthy survivors of cancer.

Authors:  E De Caro; F Fioredda; M G Calevo; A Smeraldi; M Saitta; G Hanau; M Faraci; F Grisolia; G Dini; G Pongiglione; R Haupt
Journal:  Arch Dis Child       Date:  2005-09-27       Impact factor: 3.791

4.  Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.

Authors:  Lubomir Elbl; Hana Hrstkova; Iva Tomaskova; Bohumir Blazek; Jaroslav Michalek
Journal:  Eur J Pediatr       Date:  2005-07-26       Impact factor: 3.183

5.  Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia.

Authors:  Emily S Tonorezos; Peter G Snell; Chaya S Moskowitz; Debra A Eshelman-Kent; Jennifer E Liu; Joanne F Chou; Stephanie M Smith; Andrea L Dunn; Timothy S Church; Kevin C Oeffinger
Journal:  Pediatr Blood Cancer       Date:  2013-02-15       Impact factor: 3.167

6.  Recovery kinetics of heart rate and oxygen uptake in long-term survivors of acute leukemia in childhood.

Authors:  Gernot Bär; Peter C Black; Peter Gutjahr; Herwig Stopfkuchen
Journal:  Eur J Pediatr       Date:  2007-03-31       Impact factor: 3.183

Review 7.  Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.

Authors:  Mohamed Aissiou; Delphine Périé; Farida Cheriet; Nagib S Dahdah; Caroline Laverdière; Daniel Curnier
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-07       Impact factor: 2.357

8.  Cardiopulmonary Exercise Testing Characterizes Silent Cardiovascular Abnormalities in Asymptomatic Pediatric Cancer Survivors.

Authors:  Takeshi Tsuda; Daphney Kernizan; Austin Glass; Gina D'Aloisio; Jobayer Hossain; Joanne Quillen
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

Review 9.  Treatment-related cardiotoxicity in survivors of childhood cancer.

Authors:  Steven E Lipshultz; Thomas R Cochran; Vivian I Franco; Tracie L Miller
Journal:  Nat Rev Clin Oncol       Date:  2013-10-29       Impact factor: 66.675

10.  The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies.

Authors:  Norihiko Senju; Satoshi Ikeda; Seiji Koga; Yoshiyuki Miyahara; Kunihiro Tsukasaki; Masao Tomonaga; Shigeru Kohno
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.